Allakos Inc.

Allakos Inc.verified

ALLK

Price:

$0.3291

Market Cap:

$29.74M

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; ...[Read more]

Industry

Biotechnology

IPO Date

2018-07-19

Stock Exchange

NASDAQ

Ticker

ALLK

The Enterprise Value as of November 2025 (TTM) for Allakos Inc. (ALLK) is 5.52M

According to Allakos Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.52M. This represents a change of -91.79% compared to the average of 67.20M of the last 4 quarters.

Allakos Inc. (ALLK) Historical Enterprise Value (quarterly & annually)

How has ALLK Enterprise Value performed in the past?

The mean historical Enterprise Value of Allakos Inc. over the last ten years is 1.69B. The current 5.52M Enterprise Value has changed -67.41% with respect to the historical average. Over the past ten years (40 quarters), ALLK's Enterprise Value was at its highest in in the December 2020 quarter at 7.04B. The Enterprise Value was at its lowest in in the March 2025 quarter at -3762442.80.

Quarterly (TTM)
Annual

Average

1.69B

Median

945.89M

Minimum

93.84M

Maximum

6.76B

Allakos Inc. (ALLK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Allakos Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 326.62%

Maximum Annual Enterprise Value = 6.76B

Minimum Annual Increase = -93.71%

Minimum Annual Enterprise Value = 93.84M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202493.84M-55.72%
2023211.92M-57.17%
2022494.74M16.24%
2021425.61M-93.71%
20206.76B58.08%
20194.28B326.62%
20181.00B6.05%
2017945.89M-7.51%

Allakos Inc. (ALLK) Average Enterprise Value

How has ALLK Enterprise Value performed in the past?

The current Enterprise Value of Allakos Inc. (ALLK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

266.84M

5-year avg

1.60B

10-year avg

1.69B

Allakos Inc. (ALLK) Enterprise Value vs. Peers

How is ALLK’s Enterprise Value compared to its peers?

Allakos Inc.’s Enterprise Value is less than Harpoon Therapeutics, Inc. (829.47M), greater than LianBio (-40025352.00), greater than Metacrine, Inc. (-62299000.00), greater than Freeline Therapeutics Holdings plc (-13071904.00), less than Marinus Pharmaceuticals, Inc. (44.18M), greater than Elevation Oncology, Inc. (-7613691.00), less than Kineta, Inc. (7.37M), greater than Applied Genetic Technologies Corporation (-23895000.00), less than Odonate Therapeutics, Inc. (24.10B), less than Angion Biomedica Corp. (14.84M),

Build a custom stock screener for Allakos Inc. (ALLK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allakos Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Allakos Inc. (ALLK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Allakos Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Allakos Inc.'s Enterprise Value?

What is the highest Enterprise Value for Allakos Inc. (ALLK)?

What is the 3-year average Enterprise Value for Allakos Inc. (ALLK)?

What is the 5-year average Enterprise Value for Allakos Inc. (ALLK)?

How does the current Enterprise Value for Allakos Inc. (ALLK) compare to its historical average?